Abiopharma

🔍 Thompson Brannigan C (Executive)

Company: Voya Financial, Inc. (VOYA)

Report Date: 2026-08-16

Detailed Transactions and Holdings:

• Acquired 1,645 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,441.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 730 shares of Common Stock at $100.14 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 11,711.00 | transaction_form_type: 4
• Sold 1,645 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,798.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
• Holds 31,672 shares of Performance Stock Unit (Derivative)
  Date: 2026-08-16 | Code: H | shares_owned_after: 31,672.00 | Footnotes: F3, F3, F3
• Holds 3,617 shares of Performance-Based Stock Options (Derivative)
  Date: 2026-08-16 | Code: H | shares_owned_after: 3,617.00 | Footnotes: F4, F4, F4

Footnotes:

• F1: Delivery of shares of the company's common stock was made to the reporting person without the payment of any consideration in connection with the vesting of the underlying restricted and performance stock units that were awarded as compensation.
• F2: The restricted stock units were awarded as compensation and will convert to common stock on a 1 to 1 basis upon the vesting date.
• F3: The performance stock units were awarded as compensation and will convert to common stock based on the achievement of certain performance factors.
• F4: The options vest based on conditions set forth in their respective agreements.
• REMARKS: Executive Vice President, Chief Human Resources Officer